SCA practice case · Video consultation
“I keep getting smear test letters — last time it went really badly, and I’m not sure I even need one”
Video consultation
Adult patient
Hard
Ethnicity, culture & diversityGender, reproductive & sexual healthHealth disadvantage & vulnerabilities
The candidate brief
This is what you would read in the 3-minute window before the patient connects. Read it once, note two or three hypotheses and one thing you must not miss, then stop.
Patient
Rowan Price (registered name “Rebecca Price”, title “Miss”) · 31 years · registered sex: female
Setting
Video consultation with a non-binary person (they/them) about cervical screening.
Past history
- Gender incongruence — NHS gender service; testosterone under shared care (18 months)
- Cervical screening: last attempt 4 years ago — “procedure stopped at patient request, sample not taken”; overdue
- HPV vaccination record: 2 doses (school programme)
Medication
- Testosterone gel 16.2 mg/g — 2 pumps daily (shared care)
Allergies
NKDA
Recent notes
Gender service letter (2 months ago): “Rowan (they/them) — testosterone level within target range. Haematocrit 0.45. Amenorrhoea since month 4. Please note patient’s name and pronouns.” Shared-care monitoring bloods (6 weeks ago): haematocrit 0.46 (0.36–0.50); LFTs normal. Screening reminder letters x3 (addressed to “Miss R Price”).
Reason for contact
Video consultation: “Question about smear test letters and updating my records.”
Practise this case
The full case is in the Hot Seat with the Gold plan. You get a 12-minute timer, a role-player script with facts released only when asked, examiner checkpoints by the three RCGP domains, a model consultation and the guidance behind it.
What this case tests
Show the learning points (spoiler: read after you have practised)
Inclusive care starts with the basics: use the person’s name and pronouns, correct the record, and acknowledge past harm. Anyone with a cervix aged 25–64 who has ever been sexually active should be offered cervical screening, whatever their gender or partners’ gender; trans men and non-binary people registered as male are not invited automatically, so practices must recall them manually. Testosterone can cause vaginal atrophy, making examination uncomfortable; a short course of vaginal oestrogen beforehand may help (discuss with the patient and gender service), along with a smaller speculum, self-insertion, a chosen clinician and an explicit right to stop. Postcoital bleeding is a symptom, not a screening question: examine the cervix, test for STIs, and refer on a suspected cancer pathway if the cervix looks suspicious. Testosterone is not a contraceptive and is teratogenic; offer progestogen-only methods, IUDs and condoms. From August 2026, HPV self-sampling kits are being offered to some under-screened people in England, but self-sampling is not suitable when there are symptoms.
The guidance behind it
Similar SCA cases
gpreasoning.uk is not affiliated with or endorsed by the RCGP. Our cases are original teaching material written for practice; none is an exam recall. For anything official about the SCA, check the RCGP SCA pages.